Mindfulness may ease Parkinson's symptoms without drugs
NCT ID NCT03998462
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether an 8-week mindfulness program (MBSR) could improve quality of life, thinking, and mood in 107 people with Parkinson's disease. Participants were randomly assigned to MBSR or a supportive education group, with sessions held online due to COVID-19. The goal was to see if mindfulness training provides lasting benefits beyond standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mindfulness Based Stress Reduction (MBSR) - a structured program of weekly group sessions and a retreat, delivered online
- What this could lead to
- If it works, this could offer a drug-free way to help people with Parkinson's feel better day-to-day and manage stress.
- What could go wrong
- This is a completed study with 107 participants, but results may not apply to everyone with Parkinson's. The online format during COVID may have affected outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
107 people
The number who actually took part.
- Started
-
Jan 2020
- Finished
-
Nov 2024
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Clinical diagnosis of PD based on UK Brain Bank Criteria 2. 40 years of age or older Exclusion Criteria: 1. Secondary causes of Parkinsonism (e.g. corticobasal degeneration, progressive supranuclear palsy, drug-induced parkinsonism) 2. Other neurological conditions (e.g. stroke) 3. Clinical diagnosis of dementia based on any previous neuropsychological testing 4. Psychosis, antipsychotic treatment or treatment for substance abuse 5. Uncorrected vision or hearing to adequately participate in the intervention 6. Prior formal training in MBSR or regular current MBSR practice 7. Inability to use a computer or technology for participation 8. Active/current suicidal ideation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson's disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
VA San Diego Healthcare System
San Diego, California, 92161-0002, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Walking memory tests may reveal early Parkinson's clues
- Colon tissue may hold clues to telling Parkinson's apart from Look-Alike diseases
- A genetic roadmap for Parkinson's: testing thousands to unlock clues
- Can gentle touch therapy calm Parkinson's tremors?
- Stem cell infusions aim to slow Parkinson's progression
- Can an inhaled levodopa ease Parkinson's OFF episodes? a study asks patients.